Authors:
Jolinda de Korne (Dübendorf | CH)
Lea Caduff (Dübendorf | CH)
Matteo Carrara (Zürich | CH)
Chaoran Chen (Basel | CH)
Sheena Conforti (Dübendorf | CH)
David Dreifuss (Basel | CH)
Louis du Plessis (Basel | CH)
Lara Fuhrmann (Basel | CH)
Charlie Gan (Dübendorf | CH)
Anika John (Basel | CH)
Seju Kang (Dübendorf | CH)
Sophia Kiselova-Sammons (Lausanne | CH)
Adrian Lison (Basel | CH)
Rachel McLeod (Dübendorf | CH)
David Meyer (Zürich | CH)
James Munday (Basel | CH)
Franziska Singer (Zürich | CH)
Severin Olloz (Zürich | CH)
Melissa Pitton (Dübendorf | CH)
Auguste Rimaite (Basel | CH)
Alexander Taepper (Basel | CH)
Ivan Topolsky (Basel | CH)
Daniela Yordanova (Dübendorf | CH)
Niko Beerenwinkel (Basel | CH)
Tim Julian (Dübendorf | CH)
Tamar Kohn (Lausanne | CH)
Christoph Ort (Dübendorf | CH)
Tanja Stadler (Basel | CH)
Wastewater-based infectious disease surveillance has helped to inform dynamics of SARS-CoV-2 in Switzerland since July 2020. Wastewater analysis complements traditional epidemiological indicators, such as reported cases, offering a unique perspective on disease dynamics. Since November 2022, wastewater sampling has been expanded to include monitoring of other priority respiratory diseases. Routine sampling is conducted with high temporal (5 days a week) and spatial (14 treatment plants across Switzerland, representing 26% of the population) resolution. Wastewater samples are received at a central laboratory weekly, total nucleic acids are extracted, and RNA concentrations of SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus are quantified with a multiplex digital PCR assay offering absolute quantification. Digital PCR’s accuracy is achieved by partitioning samples into thousands of individual reactions, enabling absolute quantification without the need for standard curves. Additionally, amplicon-based sequencing and associated bioinformatics pipelines facilitate the detection of variant signature mutations and estimation of SARS-CoV-2 variant proportions in wastewater. The wastewater data collected within the scope of the work has also been used to estimate the effective reproductive number of SARS-CoV-2 and Influenza over time, complementing clinical-based measures of disease dynamics. The work highlights the potential for low cost, environmental surveillance of populations to inform Swiss infectious diseases. Intended expansions include work on surveillance of other priority pathogens, including gastrointestinal diseases, seasonal coronaviruses, and antimicrobial resistance.